Ditchcarbon
  • Contact
  1. Organizations
  2. Argenx
Public Profile
Pharmaceutical Preparation Manufacturing
NL
updated a month ago

Argenx Sustainability Profile

Company website

Argenx SE, a leading biotechnology company headquartered in the Netherlands, is at the forefront of developing innovative therapies for severe autoimmune diseases and cancer. Founded in 2008, Argenx has made significant strides in the industry, particularly with its proprietary antibody engineering platform, which enables the creation of unique therapeutic candidates. The company’s flagship product, efgartigimod, has garnered attention for its potential to transform treatment paradigms in conditions like myasthenia gravis. With a strong presence in Europe and North America, Argenx has established itself as a key player in the biopharmaceutical sector, recognised for its commitment to advancing patient care through cutting-edge science and strategic partnerships.

DitchCarbon Score

How does Argenx's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

44

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Argenx's score of 44 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Argenx's reported carbon emissions

In 2024, Argenx, headquartered in the Netherlands, reported total carbon emissions of approximately 231,769,000 kg CO2e. This figure includes 3,788,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling, amounted to about 534,000 kg CO2e (market-based). The majority of their emissions, approximately 227,447,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions in the value chain. Notably, significant contributors to Scope 3 emissions include purchased goods and services (about 183,781,000 kg CO2e) and business travel (approximately 13,340,000 kg CO2e). In 2023, Argenx's total emissions were reported at around 433,353,000 kg CO2e, with Scope 1 emissions at 378,000 kg CO2e and Scope 2 emissions at approximately 189,000 kg CO2e (market-based). The Scope 3 emissions for that year were significantly higher, at about 432,786,000 kg CO2e, primarily driven by purchased goods and services. Currently, Argenx has not set specific reduction targets or initiatives, nor do they participate in the Science Based Targets initiative (SBTi). Their emissions data is not cascaded from any parent organization, indicating that the figures are independently reported. As the company continues to grow, it may consider establishing climate commitments to align with industry standards and expectations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
378,000
0,000,000
Scope 2
189,000
000,000
Scope 3
432,786,000
000,000,000

How Carbon Intensive is Argenx's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Argenx's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Argenx's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Argenx is in NL, which has a very low grid carbon intensity relative to other regions.

Argenx's Scope 3 Categories Breakdown

Argenx's Scope 3 emissions, which decreased by 47% last year and decreased by approximately 47% since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
81%
Upstream Transportation & Distribution
11%
Business Travel
6%
Capital Goods
<1%
Employee Commuting
<1%
Fuel and Energy Related Activities
<1%
Investments
<1%
Downstream Transportation & Distribution
<1%
Franchises
<1%
Upstream Leased Assets
<1%

Argenx's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Argenx has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Argenx's Emissions with Industry Peers

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Zealand Pharma A/S

DK
•
Pharmaceutical Preparation Manufacturing
Updated about 17 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Molecular Partners AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy